Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Catalent

FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles

The U.S. Food and Drug Administration (FDA) has identified repeated quality control failures, including foreign particle contamination, inadequate investigations, and insufficient corrective actions at the Novo Nordisk A/S (NYSE:NVO) operated facility in Bloomington, Indiana.

Benzinga

Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines

On Friday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported second-quarter adjusted earnings of $12.89 per share, up 12% year-over-year, beating the consensus of $8.57.

Benzinga

Lennox To Join S&P 500 Index, Replacing Catalent

Lennox International, an AI cooling play, will join the S&P 500 before the open on Dec. 23. Bill Holdings will take its place in the S&P Midcap 400.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Eli Lilly (LLY) vs. Catalent (CTLT): Which Pharma Stock Offers Better Returns?

The pharma industry is evolving rapidly due to the ever-rising healthcare needs and increasing demand for customized medicine and treatments worldwide. So, let’s analyze Eli Lilly (LLY) and Catalent (CTLT), to determine which pharma stock offers better returns. Read more.

StockNews.com

Catalent Stock: Analyst Estimates & Ratings

Despite Catalent’s outperformance relative to the broader market over the past year, Wall Street analysts remain cautious about the stock’s prospects.

Barchart

What to Expect From Catalent's Next Quarterly Earnings Report

Catalent is expected to release its first-quarter earnings next month, and analysts expect a triple-digit profit surge.

Barchart

Catalent Stock: Is CTLT Outperforming the Healthcare Sector?

Despite Catalent’s outperformance relative to the broader sector, Wall Street analysts remain cautious about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Do Wall Street Analysts Like Catalent Stock?

While Catalent has outperformed the broader market over the past year, analysts are cautious about the stock’s potential.

Barchart

7 Stocks' Profit Growth Will Blow Past Nvidia's This Quarter

Nvidia's profit is growing fast, but not the fastest in the S&P 500. Not by a long shot, say stock analysts.

Investors Business Daily

Weight-loss Drug Maker Novo Nordisk's Profits Soar Further

The drugmaker increased its market share of the diabetic treatment market by 1.8 percentage points and now has a 34-percent share of the market.

International Business Times

Expect More Gains From 8 Fast-Rising Stocks, Analysts

Missed big runs in some S&P 500 stocks? Don't worry — it's not too late. Analysts found rising stocks with plenty of more upside.

Investors Business Daily

Europe's Most Valuable Stock Is a Must-Own Near 52-Week Highs

Despite concerns over its ability to meet surging semaglutide demand, this Danish pharmaceutical giant holds a dominant position in the diabetes and insulin markets - and now commands the lead in Europe's stock market, too. Here's why NVO is a must-own stock.

Barchart

Novo Nordisk vs. Eli Lilly: Which Mega-Cap Healthcare Stock is a Better Buy for 2024?

Healthcare stocks LLY and NVO have crushed broader market returns in the past two decades. But with competition heating up over obesity drugs, which mega-cap stock is a better buy today?

Barchart

Amgen Is Trying To Take On Lilly, Novo In Obesity Treatment — Here's Why Lilly Stock Just Hit A Record

Amgen stock slumped Monday — as Eli Lilly stock hit a record high — after the company unveiled preclinical results for its weight-loss drug.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Novo Nordisk To Up Production Capacity As Parent Buys Catalent

Shares in Novo Nordisk rose after its parent, Novo Holdings, said it has agreed to by contract drug manufacturer Catalent for $11.5 billion in cash.

Top News

Novo Holdings Acquires Catalent for .5 Billion, Expands Wegovy Capacity

Novo Holdings has announced its acquisition of Catalent for .5 billion, a move aimed at expanding the production capacity of Wegovy, a drug used for obe...

Investors Business Daily

This Stock Turned $10,000 Into $12,614 In Just One Month

How's a 26.1% gain in a month sound? It's possible with one stock in the S&P 500.

Investors Business Daily

These 9 Stocks Are Running To Start 2024

The S&P 500 rebounded last week near record highs, but is up just 0.2% so far in 2024. These are the index's top performers so far.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

12 Stocks Turn $10,000 Into $313,671 In 12 Months

Talk about a strong finish. Investors who hung onto the top S&P 500 stocks this year ended up much richer for the effort.

Investors Business Daily

11 Stocks Turn $10,000 Into $229,964 In 11 Months

Hope you didn't bail out of S&P 500 stocks after three-straight months of losses. November turned into a big moneymaker.

StockNews.com

Catalent (CTLT) Loses 6.1% Over the Past Month: Can the Stock Reverse Its Fortune?

Catalent, Inc. (CTLT) recently faced a setback, witnessing a 6.1% dip in its stock value over the last month. However, in the light of the recent release of its first quarter results of fiscal 2024, can the company reverse its fortune? Keep reading….

Investors Business Daily

BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake

Activist investor Elliott has reportedly built a $1 billion stake in BioMarin Pharmaceutical, Reuters reported Tuesday as BMRN stock rocketed.

Barchart

Stocks Finish Higher Ahead of Wednesday’s FOMC Decision

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday rose by +0.65%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose by +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose by +0.52%. Stocks on Tuesday closed moderately higher on mostly stronger-than-expected...

Barchart

Stocks Rally Off Morning Lows

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.37%. Stock indexes this afternoon are higher despite uneven corporate...

Barchart

Stocks Little Change after Mixed Corporate News and Weak Economic Reports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.12%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.02%. Stock indexes this morning are mixed on uneven corporate...

1 2 3

People

Stournaras

26 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

SP Global Market Intelligence

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.